Skip to main content

Table 4 Laboratory findings among the studied cases and comparison according to the presence of NAFLD

From: Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes

Variables

Total cases (N = 74)

NAFLD

P-value

Present (N = 46)

Absent (N = 28)

Hemoglobin

13.1 ± 1.4

12.8 ± 1.3

13.7 ± 1.2

^0.003*

RBCs

4.8 ± 0.5

4.7 ± 0.5

4.9 ± 0.4

^0.037*

Hematocrit

38.8 ± 4.1

37.7 ± 4.1

40.5 ± 3.6

^0.005*

MCHC

33.9 ± 0.9

33.9 ± 1.1

34.0 ± 0.5

^0.627

TLC

12.3 ± 5.6

12.0 ± 6.0

12.9 ± 5.0

^0.533

Platelets

354.4 ± 84.9

364.7 ± 86.5

337.5 ± 81.1

^0.184

Cholesterol

148.3 ± 43.2

161.7 ± 45.2

126.4 ± 28.8

^ < 0.001*

Triglycerides

117.1 ± 74.8

132.9 ± 88.8

91.1 ± 29.6

^0.019*

HDL

52.6 ± 8.6

50.2 ± 7.1

56.7 ± 9.4

^0.001*

LDL

71.1 ± 31.3

80.7 ± 33.4

55.5 ± 19.5

^0.001*

FBG

216.2 ± 75.6

234.5 ± 76.8

186.1 ± 64.1

^0.007*

HbA1c

10.3 ± 2.0

10.9 ± 1.7

9.3 ± 2.0

^0.001*

No. of cases with HbA1c ≥ 10.0

40 (54.1%)

30 (65.2%)

10 (35.7%)

#0.014*

Mean HbA1c/year

10.7 ± 2.0

11.2 ± 1.9

9.9 ± 1.8

^0.003*

No. of cases with mean HbA1c ≥ 10.0/year

50 (67.6%)

37 (80.4%)

13 (46.4%)

#0.002*

AST

25.5 ± 18.8

29.5 ± 22.6

19.0 ± 6.1

^0.019*

No. of cases with elevated AST

9 (12.2%)

9 (19.6%)

0 (0.0%)

§0.011*

ALT

14.4 ± 8.5

16.2 ± 10.1

11.3 ± 3.2

^0.015*

No. of cases with elevated ALT

3 (4.1%)

3 (6.5%)

0 (0.0%)

§0.285

  1. ^Independent t-test
  2. #Chi square test
  3. §Fishers exact test
  4. *Significant (p < 0.05)